SCHEMBL24403754

SCHEMBL24403754

O=c1c2cc(Br)ccc2oc2ccc(-n3c4ccccc4c4ccccc43)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ MAOA P21397 3/20 0.43
▸ GABRP O00591 3/20 0.43
▸ GABRD O14764 3/20 0.43
▸ GABRA1 P14867 3/20 0.43
▸ GABRB1 P18505 3/20 0.43
▸ GABRG2 P18507 3/20 0.43
▸ GABRB3 P28472 3/20 0.43
▸ GABRA5 P31644 3/20 0.43
▸ GABRA3 P34903 3/20 0.43
▸ GABRA2 P47869 3/20 0.43
▸ GABRB2 P47870 3/20 0.43
▸ GABRA4 P48169 3/20 0.43
▸ GABRE P78334 3/20 0.43
▸ GABRA6 Q16445 3/20 0.43
▸ GABRG1 Q8N1C3 3/20 0.43
▸ GABRG3 Q99928 3/20 0.43
▸ GABRQ Q9UN88 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29589408 0.91 KDM4E (0.43) CHRNA7KCNH2GABRPGABRDGABRA1
SCHEMBL280347 0.91 KDM4E (0.43) CHRNA7KCNH2GABRPGABRDGABRA1
SCHEMBL4572433 0.91 MAOA (0.50) CHRNA7KCNH2MAOAKDM4EALDH1A1
SCHEMBL12811628 0.89 KDM4E (0.41) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12801043 0.89 KDM4E (0.41) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL14039066 0.89 KDM4E (0.41) CHRNA7KCNH2GABRPGABRDGABRA1
SCHEMBL22905605 0.88 MAOA (0.56) CHRNA7KCNH2MAOAKDM4EALDH1A1
SCHEMBL25625682 0.88 CHRNA7 (0.48) CHRNA7KCNH2MAOAKDM4EALDH1A1
SCHEMBL14039041 0.87 KDM4E (0.40) MAOAGABRPGABRDGABRA1GABRB1
SCHEMBL24403738 0.87 CHRNA7 (0.47) CHRNA7KCNH2MAOAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220144857-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2022-05-12 — — US disclosed
EP-3995497-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE Canon Kabushiki Kaisha (JP) 2022-05-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144857-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE SPIN4, OR10J3, SPIN1 CHRNA7 2492/4885KCNH2 505/4885MAOA 864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback